Literature DB >> 15357519

How to use octreotide for malignant bowel obstruction.

Carla Ripamonti1, Sebastiano Mercadante.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357519

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


× No keyword cloud information.
  7 in total

1.  Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study.

Authors:  Megan Winner; Stephen J Mooney; Dawn L Hershman; Daniel L Feingold; John D Allendorf; Jason D Wright; Alfred I Neugut
Journal:  JAMA Surg       Date:  2013-08       Impact factor: 14.766

Review 2.  Current concepts in malignant bowel obstruction management.

Authors:  Eric Roeland; Charles F von Gunten
Journal:  Curr Oncol Rep       Date:  2009-07       Impact factor: 5.075

3.  Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital.

Authors:  Michael Hwang; Rosene Pirrello; Minya Pu; Karen Messer; Eric Roeland
Journal:  Support Care Cancer       Date:  2013-06-04       Impact factor: 3.603

4.  Decompressive percutaneous endoscopic gastrostomy in advanced cancer patients with small-bowel obstruction is feasible and effective: a large prospective study.

Authors:  Elena Zucchi; Mara Fornasarig; Luca Martella; Stefania Maiero; Emilio Lucia; Eugenio Borsatti; Luca Balestreri; Giorgio Giorda; Maria Antonietta Annunziata; Renato Cannizzaro
Journal:  Support Care Cancer       Date:  2016-02-02       Impact factor: 3.603

5.  The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research.

Authors:  Robert S Krouse
Journal:  J Pain Symptom Manage       Date:  2007-06-04       Impact factor: 3.612

6.  Use of granisetron transdermal system in the prevention of chemotherapy-induced nausea and vomiting: a review.

Authors:  Albert Tuca
Journal:  Cancer Manag Res       Date:  2009-12-16       Impact factor: 3.989

7.  The use of lanreotide autogel® in the treatment of intestinal obstruction in a patient with adenocarcinoma.

Authors:  Willem Lybaert
Journal:  Case Rep Oncol       Date:  2014-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.